Joseph Louis Capasso, PA-C

Joseph Capasso practices at Advanced Dermasurgery Associates in Cedar Hill, Texas.

Joseph Capasso's NPI, 1780733279, was assigned on January 10, 2007. Joseph Capasso holds Texas license PA03467.

Joseph Capasso's primary practice is Advanced Dermasurgery Associates, at 610 Uptown Blvd, Cedar Hill, TX 75104 in Dallas County. The practice phone is (214) 987-3376.

Joseph Capasso's primary practice is Advanced Dermasurgery Associates in Cedar Hill, Texas. The medical group on file is Dallas Associated Dermatologists. Dmand AI also links Joseph Capasso to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Joseph Capasso practices. Vendor and product names are available with a free account.

Physician assistant is Joseph Capasso's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Joseph Capasso is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Joseph Capasso is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, facial skin infection, hives and itchy rashes among the conditions Joseph Capasso treats.

CMS data shows 3,073 Medicare services from Joseph Capasso across 14 procedure codes in 2024, for 484 Medicare patients. Medicare paid $113,438 for them. Every service was in an office.

CMS counts 484 Medicare patients who saw Joseph Capasso in 2024. The largest group is 65 to 74, with 234 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Joseph Capasso's median patient age at 60, with 55% women.

In 2024, Joseph Capasso wrote 1,300 Medicare Part D claims for 470 patients. 92% of them were for generic drugs. CMS names the drug for 1,181 of them, across 23 drugs with 11 or more claims each, at $224,404 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Joseph Capasso for performance year 2024, reported as part of a group. Joseph Capasso accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 346 general payments to Joseph Capasso from 27 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 94% of the total. Sanofi and Genzyme US Companies paid the most, $953.